Back to BENJAMIN EDWARDS INC BENJAMIN EDWARDS INC

NTLANTLA

Showing 8 of 30 quarters

Position history for BENJAMIN EDWARDS INCBENJAMIN EDWARDS INC's holdings in INTELLIA THERAPEUTICS INC

Yes. Benjamin Edwards holds 80,881 shares of NTLA (Intellia Therapeutics), worth $1.4M, as of its Q2 2026 13F filing. It reduced the position by 1,682 shares (-2.0%) from Q1 2026. Benjamin Edwards has held NTLA in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$1.4M

Current Shares

80,881

Total Value Change

+$183,443

Total Shares Change

+23,212

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
80,881
-2.0%
$1.4M0.0%$16.92
0
2026-Q1
Increased
82,563
+4.3%
$1.1M0.0%$12.82
26
2025-Q4
Increased
79,200
+22.1%
$711,8980.0%$8.99
30
2025-Q3
Increased
64,850
+2.9%
$1.1M0.0%$17.27
26
2025-Q2
Increased
63,034
+1.8%
$591,2580.0%$9.38
25
2025-Q1
Decreased
61,908
-3.4%
$440,1650.0%$7.11
0
2024-Q4
Increased
64,065
+11.1%
$746,8600.0%$11.66
27
2024-Q3
Increased
57,669
+138x
$1.2M0.0%$20.55
41

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used